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Abstract
Background: The rates of angioedema amongst African American patients using angiotensinconverting- enzyme- inhibitors (ACE-I) are five times greater than non-African American
counterparts (01.-07 percent vs. 0.5-3.5 percent). Although ACE-I agents are widely prescribed,
they have less therapeutic control in hypertension amongst this group of patients and high
incidences of life threating side effects.
Methods: The purpose of this quality improvement (QI) project was to assess provider
knowledge related to established guidelines from the Joint National Committee (JNC) on
hypertension management, as well as their knowledge of the side effects of ACE-I for African
American patients. A pre interventions survey was conducted to assess knowledge of established
guidelines for hypertension management and risks associated with use of ACE-I in African
American patients. The staff was then educated on current guidelines as well as where to access
them, and also on the risks of ACE-I and alternative options for African American patients and a
post intervention survey was issued to assess knowledge gained from the intervention.
Results: Following the educational intervention, all participants were able to identify resources
related to guidelines for hypertensive management. However, only 75% of staff were able to
recall potential adverse side effects of ACE-I use in African American patients.
Conclusion: The results of this QI project support the effectiveness of an educational program
addressing ethnic considerations in the prescribing of ACE-I for African American patients.
Keywords: African American, angioedema, hypertension, ACE-I
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Hypertensive Management for African American Patients
Introduction
Hypertension among African Americans is proportionately higher than other
races. By the age of sixty-five, African American patients are 65% more likely to have
developed hypertension (Ferdinand, 2003) (see Appendix A for hypertension
demographic bar graph). Many genetic, cultural, pathological and even geographical
components make this population susceptible to hypertension (Ferdinand, 2003;
Ogedegbe, 2015).
Background
Although well recognized institutions such as the American Society of
Hypertension have developed effective hypertension management; leading institutions
such as the American College of Cardiology (ACC) and the American Heart Association
(AHA) have limited research regarding ethnic considerations for hypertension. The need
for ethnic based hypertension management is needed and proper pharmaceutical drug
selection must be tailored to patient needs. For example, the use of angiotensin
converting enzyme inhibitors (ACE-I) amongst African American patients has shown
decreased effectiveness and increased morbidity and mortality (Ferdinand, 2003).
Despite the evidence, many providers still prescribe ACE-I as first line management with
this population. The gap in evidence vs. practice can be attributed to the lack of
representation in hypertensive studies amongst African Americans (Ogedegbe, 2015).
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Problem Statement
Due to genetic makeup and ethnic components, African Americans respond
differently to the treatment of hypertension with ACE-I (Ogedegbe, 2015). Appropriate
education on current guidelines and recommendations is necessary to ensure proper
prescription thus decreasing adverse reactions. The increased risk of angioedema in
African Americans prescribed ACE-I for hypertension requires a need for culturally
appropriate guidelines and education for prescribing providers. Providing the current
published guidelines on hypertensive management and evaluating the competency of
local providers, will help reiterate the importance of ethnic consideration in hypertensive
management. Furthermore, decreases in adverse reaction and better therapeutic control
will be evident.
Organizational “gap” Analysis of Project Site
The proposed site is a primary care facility. The site has no clear guidelines for
the management of hypertension and their reference resources are outdated. Although this
capstone project does focus on African American patients, the established guidelines
consist of best practice for all patients including those with chronic illnesses (James et al.,
2014). The providers will be given these resource to improve their practice and
prescribing methods. The purpose of the capstone project is to ensure that 100% of staff
know how to access the current guidelines on hypertension management to adequately
prescribe medication for African American patients. This will consequently decrease the
high prescriptions of ACE-I amongst this population as first line management which has
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proven to be less effective in controlling hypertension along with carrying life threatening
side effects (angioedema).
Review of the Literature
A comprehensive review was conducted using CINAHL complete, PubMed and
UpToDate. The following Medical Subject Headings (MeSH) terms were used for
CINAHL: African American and/or blacks, hypertension, ACE and angioedema.
UpToDate search consisted of MeSH terms of angioedema and ACE inhibitor. The
MeSH terms used on PubMed included use of angioedema and African Americans.
The CINAHL search resulted in 55,575 articles. This was reduced by selecting
academic journals and eliminating the MeSH term “black” resulting in four articles.
UpToDate resulted in 52 articles and was further reduced by using specific inclusion
criteria terms such as “African Americans” which resulted in four articles. PubMed
originally produced 24 articles and was further narrowed by reducing the publication date
to the last 10 years resulting in nine articles. Boolean phrases of angioedema AND ACE
AND African Americans OR Blacks resulted in a total of 17 possible articles. Due to the
limited research amongst African Americans and hypertension, reducing the article to the
standard last five years produced limited valid research to form a proper review of the
data. A total of eight articles were selected to review the literature. The articles chosen
consist of peer review, medical journals, nursing journals and practice guidelines.

ACE-I Prescription in African Americans
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Ogedegbe (2015) proposes that the large disparity between hypertension
management and African Americans, is the lack of research focused around their unique
medical needs. The continued prescription of ACE-I for management of African
Americans not only has adverse consequences, such as angioedema, but the therapeutic
effects have proven to be futile (Ogedegbe, 2015). Kupfer, Ramachadran and Tessler
(2010) conducted extensive research and case studies of African Americans who
developed angioedema after ACE-I use. The studies demonstrated severe angioedema
which resulted in tracheostomies and acute, long term level care (Kupfer et al., 2010).
The research further identified extreme risk factors in ACE-inhibitor induced angioedema
due to the swelling not being preceded by general warning signs (uticaria, rash) and the
presence of normal C4 and C1 inhibitor levels (Kupfer et al., 2010). Kupfer et al. (2010)
discussed that genetic factors such as vasoactive peptide bradykinin may play a role in
the susceptibility to ACE-I induced angioedema in African Americans. The bradykinin
enzyme can cause vasodilation and capillary leakage which can cause angioedema
(Kupfer et al., 2010). Furthermore, evidence-based treatment for reactions such as use of
“corticosteroids, antihistamines and catecholamine’s have no proven efficacy in the
treatment of ACE inhibitor-induced angioedema” (Kupfer et al., 2010). Ferdinand (2003)
conducted further research which concluded that other first line options, such as thiazidetype diuretics and calcium channel blockers not only decreased the occurrence of
angioedema, but provided better blood pressure control in African Americans. Ferdinand
(2003) also reviewed one of the very few studies that included African Americans. This
study was called the Antihypertensive and Lipid Lowering Treatment to Prevent Heart
Attack Trial (ALLHAT). This trial further confirmed the need for changes in first line
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treatment for African Americans by demonstrating increased stroke risk with ACE-I use
compared to non-African American groups (Ferdinand, 2003).
Angioedema and ACE-Inhibiter Frequency
Morimoto et al. (2003) explored ways to eliminate the use of ACE-I because of
the increase of adverse drug side effects. Not only was an increased risk for angioedema
apparent with African Americans but also East Asians developed cough and
hyperkalemia (Morimoto et al., 2003). This study went a step beyond angioedema and
explored the other comorbidities associated with ACE-I use which further proved ethnic
based selection for antihypertensive would be beneficial. Guyer and Banerji (2015) as
well as Lin and Shah (2008) found that ACE-I use was the leading cause of drug induced
angioedema in the United States (see Appendix B for angioedema plot chart).
The rate of emergency room visits due to angioedema from ACE-I, is reported to
be as high as 40% (Guyer & Banerji, 2015). With over 40 million patients in the United
States prescribed ACE-I for hypertension, myocardial infarction, heart failure, diabetes
and chronic kidney disease; the risk for adverse effects is exponentially elevated (Guyer
& Banerji, 2015). Two reported studies examined the rates of angioedema in patients
taking ACE-Is: OCTAVE trial and ONTARGET trail (Guyer & Banerji, 2015). The later
demonstrated a rate of 68% in developing angioedema within six months with the use of
enalapril, an ACE-I (Guyer & Banerji, 2015). These results were five times greater in
African American patients (Flattery, 2011). A multicenter study of the ER revealed that
the most common presenting symptoms were shortness of breath, dyspnea, tongue and lip
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swelling (Flattery, 2011). Twenty percent of these patients developed life threatening
airway obstruction (Flattery, 2011).
Evidence-Based Practice: Verification of Chosen Option
The current developed guidelines through the JNC-8 outline a stepwise approach
in managing hypertensive patients, decreasing adverse drug effects and promoting
therapeutic control (James et al., 2014). These guidelines are supported by clinical
evidence that have been developed for use by providers in all settings. However, current
research and literature has shown a disconnect in the published practices and clinical
guidelines which demonstrates a need for practice evaluation and interventions.
Theoretical Framework
Campinha-Bacote (2002) developed a theoretical framework surrounding the idea
of cultural competence in healthcare. Her model focuses on the patients as the teachers
and providers as continually tailoring and changing their care to fit the patient (students)
(Campinha-Bacote, 2002). Her framework of cultural competence, requires that the
provider continually learn and strive to become cultural competent. This entails tailoring
medications and teachings to fit our patients specific need. In the case of ACE-I use and
African American patients; the framework would urge providers to recognize the
negative benefits in this population and use this knowledge to change prescription
protocols to meet the patients’ needs.
Campinha-Bacote’s (2002) theory encompasses a continuum of care model. It is
projected that cultural competency is attained along a continuum and that we are forever
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learning new ways to treat our patients and achieve cultural competence. This model
assumes that cultural competence is achieved through five distinct steps: cultural
awareness, cultural knowledge, cultural skills, cultural encounters and last, cultural
desire. If we do not have a desire to be culturally inclined, we will not take considerations
of culture into our practice.
Understanding that culture, ethnicity, and medication continue to change and
improve; can better allow the provider to maintain an open mind and understand that all
treatment option is not the same. Furthermore, Campinha-Bacote ascertains that there is a
direct correlation in provider competence level and their ability to provide ethnic care.
Providers who are more competent, through education, training and literature; for
example, tend to have greater understanding and acceptability of cultural considerations
in patient management. This is a key component in ensuring specific, attainable goals in
managing patients of all ethnicities.
Methods
Project Design
This QI project provided education to healthcare providers and essential staff to
ensure evidence- based prescribing practices in the management of hypertension in
African Americans. A pre-assessment questionnaire was administered to assess the staff’s
current knowledge on prescribing of anti-hypertensive medication (see Appendix H for
the pre assessment questionnaire). Following the pre-assessment, the DNP student
reviewed established hypertension guidelines and reviewed pre-designed pamphlets with
providers and staff (see Appendix D for current JNC 8 guidelines). Following a period of
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two weeks, a post intervention assessment was administered which included both the
questions in the original questionnaire as well as open-ended questions where providers
were able to note any potential barriers to implementation of the new evidence- based
standards (See Appendix I for post intervention survey).
Implementation Plan/Procedures
Education was provided in the form of verbal presentation by the DNP student
during individual meetings. Initially, the education was to be conducted as a group setting
during staff meetings. However, due to the complexity and staffing of the office a group
training was not possible. The presentation reviewed existing guidelines by the Joint
National Committee (JNC) and handouts that included information related to ethnic
considerations in hypertension management (see Appendix E for DNP developed flyer).
During time with staff, the DNP student assisted in clarifying educational material in
regards to hypertension management with African American patients. The
implementation lasted two weeks after receiving the educational materials. During this
time the DNP student acted as a resource in obtaining additional information on
established guidelines for clinical practice.
Goals /Objectives
The goals and objectives of this project was to ensure that 100% of prescribing
staff and essential administration receive the published guidelines and understand the risk
factors in prescribing ACE-I for African American patients. A post intervention survey
was conducted after two weeks to review any barriers to implementation. Opportunities
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for learning and dialogue was available by the DNP student to assist in clarification of
current guidelines throughout implementation.
Data Analysis
Descriptive statistics were used to compare the results of the pre and post
implementation survey.
Description of the Medical Group and Patient Population
The project took place in a primary care setting in the southwest. The
demographics of the staff consisted of one medical doctor (MD), two Nurse practitioners
(NP), one licensed vocational nurse (LVN) and 4 medical assistants (MA’s). The
electronic charting system provides patient resources through Lippincott, Epocrates and
Medscape. The policies and procedure guidelines are developed by the managing
physician who references Lippincott.
The facility has an average patient census of 30 patients per day, 50% of which
are state funded or government funded insurance and the additional 50% consisting of
cash payment and PPO groups. The average population serviced at the clinical site
consists of middle income households. The average patient age is 54 years old. The
patient demographics are approximately 50% Hispanic, 30% African American, and 20%
mixed race and other.
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Ethics and Human Subjects Protection
Prior to the project being initiated, it was reviewed by the University of
Massachusetts Amherst Institutional Review Board (IRB) and was determined to not
meet criteria for requiring IRB approval. The project was classified as a QI project.
Results
The pre intervention survey demonstrated that 100% (n=8) of staff acknowledged
that ethnic based consideration should be considered when prescribing medications.
Seventy- five percent ( n=5) of the staff were aware that published guidelines for African
American patient and hypertension existed however none were able to state which
organization published these guidelines. Twenty-five percent (n=2) were able to cite a
resource available to access prescribing information. Seventy-five percent(n=5) of staff
agreed that it is very important for providers to consider a holistic approach when
prescribing medications.
After educating the providers with the published information, three of the eight
staff had additional questions regarding the project information. Further resources were
provided on hypertension management from the American Heart Association (See the
appendix I for AHA). Following the educational intervention, all participants (n=8) were
able to identify resources related to guidelines for hypertensive management. However,
only 75% ( n=5) of staff was able to recall potential adverse side effects of ACE-I use in
African American patients. Overall, the quality improvement project demonstrated a 25%
(n=2) increase from the pre intervention survey (See Appendix J for charts).
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Discussion/Interpretation
The intervention improved staff knowledge of published hypertensive guidelines
issued through the JNC. The initial pre intervention survey demonstrated a lack of
knowledge related to where the published guidelines could be accessed, although all staff
agreed that ethnic based guidelines should exist. Furthermore, providers were able to
identify that potentially harmful side effects from pharmaceuticals can effect certain
ethnic groups.
Although published guidelines do exist, they may not be disseminated well
throughout medical clinics due to a lack of accessibility or provider knowledge on how to
access this resource. Many patients may not be receiving best practices related to
prescribing of antihypertensive medications, which can ultimately effect their safety.
Further clinical studies on African American patients need to be conducted to help
understand ethnicity and pharmacopeia.
Campinha-Bacote’s theoretical framework stresses the importance of utilizing the
patient response to make culturally competent decisions in healthcare. The theory stresses
the importance of treating the patient, not the disease, and learning to tailor our medical
practices towards patient response. In regards to hypertensive management, we should be
aware that there are increased risks in African American patients with use of ACE-I.
Although this medication is affordable, highly prescribed, and generally well tolerated in
others; it is imperative that we take time to assess our patient fully and review evidencebased research and guidelines which support alternative options.
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When we incorporate ethnicity into the complexities of genetics and
pharmacopeia, we need to consider patient response and patient trends. African
Americans have specific needs due to their genetic makeup. Many medications will not
work the same as their counterparts. Therefore, taking an individualized approach to
prescribing all medications, not just antihypertensive, should encourage ethnic
considerations.
Facilitators and barriers. Educating the staff as a group, as originally planned
proved to be difficult due to the staffing patterns at the office and the need for staff to
attend patient care responsibilities.
Conclusion
The results of this QI project support the effectiveness of an educational program
in addressing ethnic considerations in the prescribing of ACE-I for African American
patients. This QI project demonstrated that there is a need for education and resources
regarding the use of ACE-I in this population. Evidence-based practices related to the
prescription of ACE-I need to be more widely disseminated. In addition, the use of
Angiotensin II receptor blockers (ARB) should be further studied in African American
patients as some studies suggest these should also be avoided. Further research in regards
to ethnicity and response to hypertension treatment should be conducted.

ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS

17

References
American Heart Association. (2013). Controlling hypertension in adults. Retrieved from,
http://www.heart.org/idc/groups/heartpublic/@wcm/@hcm/documents/downloadable/ucm_461839.pdf
Campinha-Bacote, J. (2002, July). The process of cultural competence in the delivery of
healthcare services: A model of care. Journal of Transcultural Nursing, 13(3),
291-292.
Corbie-Smith, G., Thomas, S. B., Williams, M. V., & Moody-Ayers, S. (1999). Attitudes
and Beliefs of African Americans Toward Participation in Medical
Research. Journal of General Internal Medicine, 14(9), 537–546.
http://doi.org/10.1046/j.1525-1497.1999.07048.x
Ferdinand, K. (2003). Hypertension treatment in ethnic populations. American Journal of
Hypertension, 16(11), 50S-54S.
Flattery, M. (2011, April). When ACE inhibitors cause angioedema. American Nurse
Today, 6(4).
Guyer, A., & Banerji, A. (2015). ACE inhibitor-induced angioedema. UpToDate, 1-20.
Haymore, B., Yoon, J., Mikita, C., Klote, M and DeZee, K. (2008). Risk of angioedema
with angiotensin receptors blockers in patients with prior angioedema associated
angiotensin-converting enzyme inhibitors: a meta-analysis. Annuals of Allery,
Asthma and Immunology, 101(5), 495-499. doi:10.1016/S1081-1206(10)60288-8

ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS

18

James, P., Oparil, S., Carter, B., Cushman,W., Himmelfarb, C., Handler, J… Ortiz, E.
(2014). 2014 Evidenced based guidelines for the management of high blood
pressure in adults: Report from the panel members appointed to the eight joint
national committee (JNC 8). Journal of American Medical Association, 311(5),
507-520.
Kupfer, Y., Ramachandran, K., & Tessler, S. (2010). ACE Inhibitor induced angioedema
in elderly African American femaes requiring tracheostomy. Journal of the
National Medical Association, 102(6), 529-530.
Lin, R. & Shah, S. (2008). Increasing hospitalizations due to angioedema in the United
States. Annuals of Allergy, Asthma and Immunology, 101.
Morimoti, T., Gandhi, T., Fisko, J., Seger, A., So, J., Cook, F. & Bates, D. (2003). An
evaluation of risk factors for adverse drug events associated with angiotensinconverting enzyme inhibitors. Journal of Evaluation in Clinical Practice, 10(4),
499-509.
Ogedegbe, G. (2015, September). Popular hypertension drugs linked to worse heart
health outcomes in hypertensive African Americans compared to Whites. New
York, NY, USA.
University of Massachusetts. (2016). Research administration and compliance. Retrieved
from, https://www.umass.edu/research/guidance/activities-involving-humansubjects-research

ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS
Appendix A

19

ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS
Appendix B

20

ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS
Appendix C

21

ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS

Ethnic considerations in
the management of
hypertension amongst
African Americans can
aid in decreased
mortality and morbidity.
The Use of ACE-I,
although popular, have
detrimental side effects
in African Americans and
show poor management
of cardiovascular control
(Ogedegbe,, 2015).

Aleksandrya Asiedu
University of Massachusetts Amherst
Doctorate in Nursing Practice Capstone
Fall 2017

Appendix D

Ethnic based
considerations in
managing African
Americans and
Hypertension
Why the use of ACE-I as first line
management is controversial in
African Americans

22

ALTERNATIVES TO ACE-I IN AFRICAN AMERICANS

23

Appendix E
Table 1
Budget analysis
Items

Price

Copies/ Materials

$0.50 X 30=$15.00

Total

$5.50 poster board

Time

$55 X 10= $550

Transportation/fuel $2.80 X 18 gallons=
$50.40

$620.90
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Appendix F
Table 2
Timeline
Week

Objective

Follow up

1-2

Assessment of current staff
knowledge

Gather materials and
organize time with medical
director to approve and
introduce material

Administer pre assessment
2-4

1 month

Provide established JNC
guidelines and DNP
developed handout

Administer post assessment

Answer and clarify any
questions from providers
Provide additional
established guidelines as
needed
Address any concerns and/
or barriers
Provide resources and
guidelines

2 months

Quantify data and analyze
results

Provide any additional
resources to ensure
longevity of guidelines
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Appendix G
Pre-intervention survey for hypertensive management in African Americans

1) Were you aware that guidelines exist to help prescribe anti hypertensive for
patients?
Yes or No

2) Do the published guidelines and handouts provide the tools needed to prescribe
medication for this population?
Strongly agree/ agree/ undecided/ disagree/ strongly disagree

3) How likely will this capstone project help you to consider ethnicity in prescribing
and diagnosing for future patient populations?
Very frequently/ frequently/occasionally/ rarely/never

4) How important is it for providers to consider a holistic approach (considering
patients social, economical, cultural, ethnicity and religious backgrounds) in
prescribing care and medications?
Very important/ important/ moderately important/ of little importance/
unimportant
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Appendix H
Post intervention survey for hypertensive management in African Americans
1) Were you aware that guidelines exist to help prescribe anti hypertensive for
patients?
Yes or No
2) Do the published guidelines and handouts provide the tools needed to prescribe
medication for this population?
Strongly agree/ agree/ undecided/ disagree/ strongly disagree
3) How likely will this capstone project help you to consider ethnicity in prescribing
and diagnosing for future patient populations?
Very frequently/ frequently/occasionally/ rarely/never

4) How important is it for providers to consider a holistic approach (considering
patients social, economical, cultural, ethnicity and religious backgrounds) in
prescribing care and medications?
Very important/ important/ moderately important/ of little importance/
unimportant
5) What is one risk involved with ACE-I?
6) Describe one reason why African American patients should avoid first line
treatment with ACE-I?
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Figure 1. Staff demographics of capstone project
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Figure 2. Pre intervention and post intervention survey comparison
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